Search

Your search keyword '"Field, Thalia"' showing total 890 results

Search Constraints

Start Over You searched for: Author "Field, Thalia" Remove constraint Author: "Field, Thalia"
890 results on '"Field, Thalia"'

Search Results

1. Classification of Alzheimers Disease with Deep Learning on Eye-tracking Data

4. Intravenous alteplase versus tenecteplase in patients with acute posterior circulation strokes: A secondary analysis from the AcT randomized controlled trial

5. Specialist Perspectives on the Imaging Selection of Large Vessel Occlusion in the Late Window

7. Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

8. External validation of the SI2NCAL2C score for outcomes following cerebral venous thrombosis

10. Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study

13. Sex-Based Analysis of Workflow and Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase Versus Tenecteplase

17. Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials

18. Neuroimaging standards for research into small vessel disease—advances since 2013

19. Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis

20. Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial

23. Management of blunt cerebrovascular injuries at a Canadian level 1 trauma centre: Are we meeting the grade?

24. Time Course of Early Hematoma Expansion in Acute Spot-Sign Positive Intracerebral Hemorrhage: Prespecified Analysis of the SPOTLIGHT Randomized Clinical Trial

26. Infarcts in a New Territory: Insights From the ESCAPE-NA1 Trial

27. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial

32. Patterns of blood pressure response during intensive BP lowering and clinical events: results from the secondary prevention of small subcortical strokes trial

34. Reducing the global burden of cerebral venous thrombosis: An international research agenda

35. An interrupted time-series analysis of the impact of COVID-19 on hospitalizations for vascular events in three Canadian provinces

38. Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled Trial

41. Contributors

43. Prevalence of Walking Limitation After Acute Stroke and Its Impact on Discharge to Home

45. Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase

46. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis

47. A Randomized Controlled Trial of Tenecteplase Versus Standard of Care for Minor Ischemic Stroke with Proven Occlusion (TEMPO-2): Rational and design of a multicenter, randomized open-label clinical trial.

48. Effect of incomplete reperfusion patterns on clinical outcome: insights from the ESCAPE-NA1 trial.

49. Time From Hospital Arrival Until Endovascular Thrombectomy and Patient-Reported Outcomes in Acute Ischemic Stroke.

Catalog

Books, media, physical & digital resources